Wen-Chi Foo

401 total citations
6 papers, 285 citations indexed

About

Wen-Chi Foo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Wen-Chi Foo has authored 6 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Wen-Chi Foo's work include Urinary and Genital Oncology Studies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Wen-Chi Foo is often cited by papers focused on Urinary and Genital Oncology Studies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). Wen-Chi Foo collaborates with scholars based in United States. Wen-Chi Foo's co-authors include Katherine M. LaFiura, Roger E. McLendon, Jeremy N. Rich, Anita B. Hjelmeland, Christine E. Eyler, Madelyn Lew, Michael H. Roh, Ajay Gopalakrishna, Brant A. Inman and Richmond Owusu and has published in prestigious journals such as Stem Cells, Annals of Surgical Oncology and Oncotarget.

In The Last Decade

Wen-Chi Foo

6 papers receiving 283 citations

Peers

Wen-Chi Foo
Comparison fields: 5 of 43
  • Molecular Biology 153
  • Oncology 146
  • Cancer Research 76
  • Genetics 70
  • Pulmonary and Respiratory Medicine 61
Replace Raffaella Albano with:
Raffaella Albano Italy
Yumiko Shinohe Japan
Dong Hyuck Ahn South Korea
Mikhail Burmakin Sweden
Luana Lamura Italy
Christine F. O’Neill United States
Shao-Yan Xi China
Cinthia Amiñoso Spain
Elisenda Alsina‐Sanchís Spain
Waldemar Och Poland
Raffaella Albano Italy View profile →
Citations per field, relative to Wen-Chi Foo
Wen-Chi Foo · 1×
Citations per year, relative to Wen-Chi Foo
Wen-Chi Foo · 1×

Countries citing papers authored by Wen-Chi Foo

Since Specialization
Citations

This map shows the geographic impact of Wen-Chi Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Chi Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Chi Foo more than expected).

Fields of papers citing papers by Wen-Chi Foo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Chi Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Chi Foo. The network helps show where Wen-Chi Foo may publish in the future.

Co-authorship network of co-authors of Wen-Chi Foo

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Chi Foo. A scholar is included among the top collaborators of Wen-Chi Foo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Chi Foo. Wen-Chi Foo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
# Work Indexed citations
1 20
2 18
3 40
4 19
5 7
6 181

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026